{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:24:23Z","timestamp":1777857863673,"version":"3.51.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Health Serv"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:p>In New Zealand in 1993, a pharmaceutical management agency (PHARMAC) was established during the height of neoliberal reforms in the health sector. The agency's relationship with pharmaceutical companies, patient lobby groups, and health professionals has been hostile at times, but despite this hostility, PHARMAC has remained substantially independent from political interference. This article draws on critical theory and Durkheimian perspectives to explain how such a strong regulatory organization was established during a time when attempts were made to reshape the health sector to conform to a neoliberal agenda. An analysis of historical and contemporary issues demonstrates the contradictory position of the state in relation to the regulation and subsidization of pharmaceuticals, with conflicting demands to retain popular support, restrain state expenditure, and respond to expectations to provide pharmaceuticals to its citizens. This article demonstrates how the establishment of PHARMAC reconciles these contradictory demands, arguing that it removes decision making from political control and has been able to sustain its place by appealing to objective assessment criteria. This case signals limits of the neoliberal agenda.<\/jats:p>","DOI":"10.2190\/hs.44.1.h","type":"journal-article","created":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T21:44:38Z","timestamp":1392327878000},"page":"137-153","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Limits to Neoliberal Reforms in the Health Sector: The Case of Pharmaceutical Management in New Zealand"],"prefix":"10.1177","volume":"44","author":[{"given":"Kevin","family":"Dew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,1,1]]},"reference":[{"key":"bibr1-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.1215\/03616878-25-5-815"},{"key":"bibr2-HS.44.1.h","unstructured":"Pharmaceutical Management Agency. Introduction to PHARMAC. October 26, 2010. http:\/\/www.pharmac.govt.nz\/2008\/12\/16\/01_PHARM_Infsheet_INTRO.pdf."},{"key":"bibr3-HS.44.1.h","unstructured":"Metcalfe S.,  PHARMAC measures savings elsewhere to the health sector. N. Z. Med. J. 116, 2003."},{"key":"bibr4-HS.44.1.h","volume-title":"Organisational Effectiveness: Debates Behind Measurement Issues in the Public Health Sector","author":"Wynn-Williams K.","year":"2009"},{"key":"bibr5-HS.44.1.h","volume-title":"Pharmacy in New Zealand: Aspects and Reminiscences","author":"Combes R.","year":"1981"},{"key":"bibr6-HS.44.1.h","volume-title":"The negotiation and re-negotiation of occupational control: A study of retail pharmacy in New Zealand","author":"Norris P.","year":"1993"},{"key":"bibr7-HS.44.1.h","volume-title":"For Health or Profit: Medicine, the Pharmaceutical Industry, and the State in New Zealand","author":"Baker A.","year":"1992"},{"key":"bibr8-HS.44.1.h","volume-title":"Judicial Review of PHARMAC","author":"Groshinski K.","year":"1996"},{"key":"bibr9-HS.44.1.h","volume-title":"Private Interests and Public Money: The State Provision of Medicines in New Zealand 1938\u20131986","author":"Baker A.","year":"1996"},{"key":"bibr10-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.1071\/AH040171"},{"key":"bibr11-HS.44.1.h","volume-title":"For Health or Profit: Medicine, the Pharmaceutical Industry, and the State in New Zealand","author":"Norris P.","year":"1992"},{"key":"bibr12-HS.44.1.h","volume-title":"Evaluating the Impact of a National Hospital Pharmaceutical Strategy in New Zealand","author":"Tordoff J.","year":"2007"},{"key":"bibr13-HS.44.1.h","volume-title":"Choices for Health Care: Report of the Health Benefits Review","author":"Health Benefits Review Committee","year":"1986"},{"key":"bibr14-HS.44.1.h","volume-title":"Health Facts New Zealand","author":"Hyslop J.","year":"1983"},{"issue":"7758","key":"bibr15-HS.44.1.h","first-page":"1224","volume":"340","author":"Cumming J.","year":"2010","journal-title":"BMJ"},{"key":"bibr16-HS.44.1.h","volume-title":"New Zealand Health System Reforms","author":"Quin P.","year":"2009"},{"key":"bibr17-HS.44.1.h","volume-title":"Unshackling the Hospitals","author":"Hospital and Related Services Taskforce","year":"1988"},{"key":"bibr18-HS.44.1.h","volume-title":"The Best of Health 2: How We Decide on the Health and Disability Support Services We Value Most","author":"National Advisory Committee on Core Health and Disability Support Services","year":"1993"},{"key":"bibr19-HS.44.1.h","volume-title":"Drug deals, dollars and decisions: An ethical and legal evaluation of the role of PHARMAC in health rationing","author":"Sim V.","year":"2000"},{"key":"bibr20-HS.44.1.h","volume-title":"A Prescription for Pharmacoeconomic Analysis","author":"Pharmaceutical Management Agency","year":"2004"},{"key":"bibr21-HS.44.1.h","volume-title":"Negotiating the Price and Subsidy for Prescription Drugs: The Case of Lipitor in New Zealand","author":"Zhong L.","year":"2003"},{"key":"bibr22-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.2202\/1558-9544.1050"},{"key":"bibr23-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199916060-00004"},{"key":"bibr24-HS.44.1.h","volume-title":"Healthy Incentives: Canadian Health Reform in an International Context","author":"Moore D.","year":"1996"},{"key":"bibr25-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200119040-00004"},{"key":"bibr26-HS.44.1.h","volume-title":"Healthy Incentives: Canadian Health Reform in an International Context","author":"Moore D.","year":"1996"},{"key":"bibr27-HS.44.1.h","unstructured":"Begg E.,  The sorry saga of the statins in New Zealand: Pharmacopolitics versus patient care. N. Z. Med. J. 116, 2003."},{"key":"bibr28-HS.44.1.h","volume-title":"Annual Review","author":"Pharmaceutical Management Agency","year":"1998"},{"key":"bibr29-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220090-00002"},{"key":"bibr30-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.2165\/11537860-000000000-00000"},{"key":"bibr31-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.2165\/11595270-000000000-00000"},{"key":"bibr32-HS.44.1.h","volume-title":"Public Participation in PHARMAC: The Perspective of Consumer Groups","author":"Lessing C.","year":"2009"},{"key":"bibr33-HS.44.1.h","volume-title":"Healthy Incentives: Canadian Health Reform in an International Context","author":"Scott A.","year":"1996"},{"issue":"1236","key":"bibr34-HS.44.1.h","volume":"119","author":"Ellis C.","year":"2006","journal-title":"N. Z. Med. J."},{"key":"bibr35-HS.44.1.h","volume-title":"Annual Review","author":"Pharmaceutical Management Agency","year":"1997"},{"issue":"1170","key":"bibr36-HS.44.1.h","volume":"116","author":"Moodie P.","year":"2003","journal-title":"N. Z. Med. J."},{"key":"bibr37-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2004.tb06264.x"},{"key":"bibr38-HS.44.1.h","volume-title":"Health at a Glance: OECD Indicators","author":"Organisation for Economic Co-operation and Development","year":"2009"},{"key":"bibr39-HS.44.1.h","volume-title":"Annual Review","author":"Pharmaceutical Management Agency","year":"2000"},{"key":"bibr40-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.1002\/hec.931"},{"key":"bibr41-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00598.x"},{"key":"bibr42-HS.44.1.h","volume-title":"Legitimation Crisis","author":"Habermas J.","year":"1975"},{"key":"bibr43-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.1177\/048661347700900105"},{"key":"bibr44-HS.44.1.h","volume-title":"Sociological Theory and Medical Sociology","author":"Taylor S.","year":"1987"},{"key":"bibr45-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.4324\/9780203413432"},{"key":"bibr46-HS.44.1.h","volume-title":"The Elementary Forms of the Religious Life: A Study in Religious Sociology","author":"Durkheim E.","year":"1915"},{"key":"bibr47-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2007.00521.x"},{"key":"bibr48-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.3167\/9780857453396"},{"key":"bibr49-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9299.2007.00676.x"},{"key":"bibr50-HS.44.1.h","doi-asserted-by":"publisher","DOI":"10.1057\/9780230353251"}],"container-title":["International Journal of Health Services"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2190\/HS.44.1.h","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2190\/HS.44.1.h","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:02:50Z","timestamp":1777507370000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.2190\/HS.44.1.h"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.2190\/HS.44.1.h"],"URL":"https:\/\/doi.org\/10.2190\/hs.44.1.h","relation":{},"ISSN":["0020-7314","1541-4469"],"issn-type":[{"value":"0020-7314","type":"print"},{"value":"1541-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}